NIH-funded research R01 grant

Understanding how age-related blood changes affect heart disease risk in people with HIV

Official title: Evaluation of Novel Clonal Hematopoiesis Of InDEterminate Potential, Mosaic Chromosomal Alterations and CardioVascular Disease in HIV Infection (ENCODE CVD in HIV)

Funded at University of California Los Angeles · NIH-11379983 · Data updated 2026-11-12

This study looks at whether certain blood-level genetic changes and chromosome alterations in people living with HIV relate to higher risk of heart disease.

More Cardiovascular Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California Los Angeles
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startJuly 5, 2023
Project endJune 30, 2027
Funding year2026
Award (this year)$705,359
NIH project number5R01HL170600-04
Project IDNIH-11379983 on NIH RePORTER

Who could benefit from this research

Could help

Adults living with HIV who are aging and at risk for cardiovascular disease.

Less likely to help

People without HIV or those not at risk for cardiovascular disease may not benefit from these findings.

What this research studies

As HIV care improves, people live longer but face more cardiovascular issues. The research will examine clonal hematopoiesis and mosaic chromosomal alterations in blood cells of adults with HIV to see how these changes relate to heart disease risk. By analyzing blood samples and patient data, the team hopes to identify mechanisms, such as inflammatory pathways, that could be targeted to reduce cardiovascular events. The goal is to learn whether these blood changes help explain why PLWH experience more heart problems and to inform future therapies.

Why it matters

Potential benefit: If successful, findings could lead to better risk prediction and new approaches to prevent heart disease in people living with HIV.

How similar studies have gone: Previous work shows CHIP and chromosomal alterations relate to cardiovascular risk in the general population, but their role in HIV is not well understood.

Where this research is happening

  • University of California Los Angeles
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Hsue, Priscilla Y. — University of California Los Angeles
  • Study coordinator: Hsue, Priscilla Y.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.